The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
A breast biopsy is the procedure of locating a diseased tissue in the breast and collecting the specimen sample of the area for further examination and diagnosis. Breast biopsies are performed by using minimally invasive biopsy systems, owing to minimal disfigurement and pain. Non-invasive biopsy techniques provide preventive measures that assist physicians in diagnosing and treating high-risk breast cancer. This information prevents the application of chemotherapy in breast cancer, reducing the complexities of chemo-radiations. Vacuum assisted breast biopsy devices (VAB), core needle biopsies and fine needle aspiration biopsy are commonly used to perform biopsy procedures.
The global Breast Biopsy market was valued at US$ 528.7 million in 2023 and is anticipated to reach US$ 927.2 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030.
Approximately 12% women in the U.S. are likely to develop breast cancer during their lifetime. Factors contributing to rise in breast cancer cases is over consumption of alcoholic drinks, lack of physical exercise, improper diet and eating habits, high level of hormonal imbalance & exposure of skin to intense sunlight. However, limited awareness among female population and substandard healthcare facilities especially in developing regions are the factor restraining the growth of breast biopsy market.
This report aims to provide a comprehensive presentation of the global market for Breast Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Biopsy.
Report Scope
The Breast Biopsy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Breast Biopsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Breast Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- BD
- C.R. Bard
- Hologic
- Leica Biosystems
- Argon Medical Devices
- Aurora Imaging
- Carestream Health
- Cook Medical
- Fischer Medical Technologies
- Intact Medical
- Internazionale Medico Scientifica
- Metaltronica
- Sectra
- Terason
- ZAMAR CARE
Segment by Type
- Needle-Based Biopsy Systems
- Breast Biopsy Needles
- Biopsy Imaging Guidance Systems
- Others
Segment by Application
- Hospitals
- ASC
- Research Centers
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Breast Biopsy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breast Biopsy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Needle-Based Biopsy Systems
1.2.3 Breast Biopsy Needles
1.2.4 Biopsy Imaging Guidance Systems
1.2.5 Others
1.3 Market by Application
1.3.1 Global Breast Biopsy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 ASC
1.3.4 Research Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Breast Biopsy Market Perspective (2019-2030)
2.2 Breast Biopsy Growth Trends by Region
2.2.1 Global Breast Biopsy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Breast Biopsy Historic Market Size by Region (2019-2024)
2.2.3 Breast Biopsy Forecasted Market Size by Region (2025-2030)
2.3 Breast Biopsy Market Dynamics
2.3.1 Breast Biopsy Industry Trends
2.3.2 Breast Biopsy Market Drivers
2.3.3 Breast Biopsy Market Challenges
2.3.4 Breast Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Breast Biopsy Players by Revenue
3.1.1 Global Top Breast Biopsy Players by Revenue (2019-2024)
3.1.2 Global Breast Biopsy Revenue Market Share by Players (2019-2024)
3.2 Global Breast Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Breast Biopsy Revenue
3.4 Global Breast Biopsy Market Concentration Ratio
3.4.1 Global Breast Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Biopsy Revenue in 2023
3.5 Breast Biopsy Key Players Head office and Area Served
3.6 Key Players Breast Biopsy Product Solution and Service
3.7 Date of Enter into Breast Biopsy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Breast Biopsy Breakdown Data by Type
4.1 Global Breast Biopsy Historic Market Size by Type (2019-2024)
4.2 Global Breast Biopsy Forecasted Market Size by Type (2025-2030)
5 Breast Biopsy Breakdown Data by Application
5.1 Global Breast Biopsy Historic Market Size by Application (2019-2024)
5.2 Global Breast Biopsy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Breast Biopsy Market Size (2019-2030)
6.2 North America Breast Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Breast Biopsy Market Size by Country (2019-2024)
6.4 North America Breast Biopsy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Breast Biopsy Market Size (2019-2030)
7.2 Europe Breast Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Breast Biopsy Market Size by Country (2019-2024)
7.4 Europe Breast Biopsy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Breast Biopsy Market Size (2019-2030)
8.2 Asia-Pacific Breast Biopsy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Breast Biopsy Market Size by Region (2019-2024)
8.4 Asia-Pacific Breast Biopsy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Breast Biopsy Market Size (2019-2030)
9.2 Latin America Breast Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Breast Biopsy Market Size by Country (2019-2024)
9.4 Latin America Breast Biopsy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Breast Biopsy Market Size (2019-2030)
10.2 Middle East & Africa Breast Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Breast Biopsy Market Size by Country (2019-2024)
10.4 Middle East & Africa Breast Biopsy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD Breast Biopsy Introduction
11.1.4 BD Revenue in Breast Biopsy Business (2019-2024)
11.1.5 BD Recent Development
11.2 C.R. Bard
11.2.1 C.R. Bard Company Detail
11.2.2 C.R. Bard Business Overview
11.2.3 C.R. Bard Breast Biopsy Introduction
11.2.4 C.R. Bard Revenue in Breast Biopsy Business (2019-2024)
11.2.5 C.R. Bard Recent Development
11.3 Hologic
11.3.1 Hologic Company Detail
11.3.2 Hologic Business Overview
11.3.3 Hologic Breast Biopsy Introduction
11.3.4 Hologic Revenue in Breast Biopsy Business (2019-2024)
11.3.5 Hologic Recent Development
11.4 Leica Biosystems
11.4.1 Leica Biosystems Company Detail
11.4.2 Leica Biosystems Business Overview
11.4.3 Leica Biosystems Breast Biopsy Introduction
11.4.4 Leica Biosystems Revenue in Breast Biopsy Business (2019-2024)
11.4.5 Leica Biosystems Recent Development
11.5 Argon Medical Devices
11.5.1 Argon Medical Devices Company Detail
11.5.2 Argon Medical Devices Business Overview
11.5.3 Argon Medical Devices Breast Biopsy Introduction
11.5.4 Argon Medical Devices Revenue in Breast Biopsy Business (2019-2024)
11.5.5 Argon Medical Devices Recent Development
11.6 Aurora Imaging
11.6.1 Aurora Imaging Company Detail
11.6.2 Aurora Imaging Business Overview
11.6.3 Aurora Imaging Breast Biopsy Introduction
11.6.4 Aurora Imaging Revenue in Breast Biopsy Business (2019-2024)
11.6.5 Aurora Imaging Recent Development
11.7 Carestream Health
11.7.1 Carestream Health Company Detail
11.7.2 Carestream Health Business Overview
11.7.3 Carestream Health Breast Biopsy Introduction
11.7.4 Carestream Health Revenue in Breast Biopsy Business (2019-2024)
11.7.5 Carestream Health Recent Development
11.8 Cook Medical
11.8.1 Cook Medical Company Detail
11.8.2 Cook Medical Business Overview
11.8.3 Cook Medical Breast Biopsy Introduction
11.8.4 Cook Medical Revenue in Breast Biopsy Business (2019-2024)
11.8.5 Cook Medical Recent Development
11.9 Fischer Medical Technologies
11.9.1 Fischer Medical Technologies Company Detail
11.9.2 Fischer Medical Technologies Business Overview
11.9.3 Fischer Medical Technologies Breast Biopsy Introduction
11.9.4 Fischer Medical Technologies Revenue in Breast Biopsy Business (2019-2024)
11.9.5 Fischer Medical Technologies Recent Development
11.10 Intact Medical
11.10.1 Intact Medical Company Detail
11.10.2 Intact Medical Business Overview
11.10.3 Intact Medical Breast Biopsy Introduction
11.10.4 Intact Medical Revenue in Breast Biopsy Business (2019-2024)
11.10.5 Intact Medical Recent Development
11.11 Internazionale Medico Scientifica
11.11.1 Internazionale Medico Scientifica Company Detail
11.11.2 Internazionale Medico Scientifica Business Overview
11.11.3 Internazionale Medico Scientifica Breast Biopsy Introduction
11.11.4 Internazionale Medico Scientifica Revenue in Breast Biopsy Business (2019-2024)
11.11.5 Internazionale Medico Scientifica Recent Development
11.12 Metaltronica
11.12.1 Metaltronica Company Detail
11.12.2 Metaltronica Business Overview
11.12.3 Metaltronica Breast Biopsy Introduction
11.12.4 Metaltronica Revenue in Breast Biopsy Business (2019-2024)
11.12.5 Metaltronica Recent Development
11.13 Sectra
11.13.1 Sectra Company Detail
11.13.2 Sectra Business Overview
11.13.3 Sectra Breast Biopsy Introduction
11.13.4 Sectra Revenue in Breast Biopsy Business (2019-2024)
11.13.5 Sectra Recent Development
11.14 Terason
11.14.1 Terason Company Detail
11.14.2 Terason Business Overview
11.14.3 Terason Breast Biopsy Introduction
11.14.4 Terason Revenue in Breast Biopsy Business (2019-2024)
11.14.5 Terason Recent Development
11.15 ZAMAR CARE
11.15.1 ZAMAR CARE Company Detail
11.15.2 ZAMAR CARE Business Overview
11.15.3 ZAMAR CARE Breast Biopsy Introduction
11.15.4 ZAMAR CARE Revenue in Breast Biopsy Business (2019-2024)
11.15.5 ZAMAR CARE Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
